Pasar al contenido principal

DESCIFRANDO LA IMPLICACION DEL CANAL DEPENDIENTE DE VOLTAJE NAV1.1 EN LA ETIOLOGIA DE LOS TRASTORNOS MENTALES

PID2021-127044OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Scn1a haploinsufficiency in the prefrontal cortex leads to cognitive impairment and depressive phenotype

  • Riga, Maurizio S.
  • Pérez-Fernández, Mercedes
  • Miquel-Rio, Lluís
  • Paz, Verónica
  • Campa, Leticia
  • Martínez-Losa, Magdalena
  • Esteban, Francisco J.
  • Callado, Luis F.
  • Meana, Javier
  • Artigas, Francesc
  • Bortolozzi, Analía
  • Álvarez-Dolado, Manuel
Altered development and function of the prefrontal cortex (PFC) during adolescence is implicated in the origin of mental disorders. Deficits in the GABAergic system prominently contribute to these alterations. Nav1.1 is a voltage-gated Na+ channel critical for normal GABAergic activity. Here, we studied the role of Nav1.1 in PFC function and its potential relationship with the aetiology of mental disorders. Dysfunction of Nav1.1 activity in the medial PFC (mPFC) of adolescent mice enhanced the local excitation/inhibition ratio, resulting in epileptic activity, cognitive deficits and depressive-like behaviour in adulthood, along with a gene expression profile linked to major depressive disorder (MDD). Additionally, it reduced extracellular serotonin concentration in the dorsal raphe nucleus and brain-derived neurotrophic factor expression in the hippocampus, two MDD-related brain areas beyond the PFC. We also observed alterations in oscillatory activity and impaired hippocampal-mPFC coherence during sleep. Finally, we found reduced expression levels of SCN1A, the gene encoding Nav1.1, in post-mortem PFC samples from human MDD subjects. Collectively, our results provide a novel mechanistic framework linking adolescence-specific alterations in Nav1.1 function in the PFC to the pathogenesis of epilepsy and comorbidities such as cognitive impairment and depressive disorders., This work was supported by the Ministerio de Ciencia Innovación y Universidades/Agencia Estatal de Investigación/European Regional Development Fund, UE Grants (RTI2018-099768-B-100; PID2021-127044OB-I00 to M.A.-D.; PID2019-105136RB-100 to A.B.; and PID2021-122991NB-C21 to F.J.E.), Asociación Apoyo Dravet to M.A.-D., Fundació La Marató de TV3 and Generalitat de Catalunya (202207) to A.B., Center for Networked Biomedical Research on Mental Health, CIBERSAM (CB/07/09/0034 and CB/07/09/0008) to A.B. and J.M., European Regional Development Fund for Andalucía 2014-2020 (US-1264375) to M.M.-L., Universidad de Jaén (PAIUJA-EI_CTS02_2023)—Junta de Andalucía (BIO-302) to F.J.E., Fundación Alicia Koplowitz (OTR08262-2021) and Asociación Síndrome STXBP1 to M.A.-D. and F.J.E., Basque Government (IT211/19 and IT1512/22) to J.M. and L.F.C., and a Consejería de Salud y Familias, Junta de Andalucía, postdoctoral fellowship (RH-0048-2020) to M.S.R., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research

  • Ruano-Rodríguez, Silvestre
  • Navarro-Alonso, Mar
  • Domínguez-Velasco, Benito
  • Álvarez-Dolado, Manuel
  • Esteban, Francisco J.
STXBP1 syndrome is a severe early-onset epileptic encephalopathy characterized by developmental delay and intellectual disability. This review addresses key challenges in STXBP1 syndrome research, focusing on advanced therapeutic approaches and experimental models. We explore gene therapy strategies, including CRISPR-Cas9, adeno-associated viral (AAV) vectors, and RNA therapies such as antisense oligonucleotides (ASOs), aimed at correcting STXBP1 genetic dysfunctions. This review presents in vivo and in vitro models, highlighting their contributions to understanding disease mechanisms. Additionally, we provide a proposal for a detailed bioinformatic analysis of a Spanish cohort of 41 individuals with STXBP1-related disorders, offering insights into specific mutations and their biological implications. Clinical and translational perspectives are discussed, emphasizing the potential of personalized medicine approaches. Future research directions and key challenges are outlined, including the identification of STXBP1 interactors, unexplored molecular pathways, and the need for clinically useful biomarkers. This comprehensive review underscores the complexity of STXBP1-related infantile epileptic encephalopathy and opens new avenues for advancing the understanding and treatment of this heterogeneous disease., This work was supported by the Asociación Síndrome STXBP1 (España), the Ministerio de Ciencia Innovación y Universidades/Agencia Estatal de Investigación/European Regional Development Fund, UE Grants (RTI2018-099768-B-100; PID2021-127044OB-I00 to A.M. and PID2021-122991NB-C21 to E.F.J.), and Universidad de Jaén (PAIUJA-EI_CTS02_2023)—Junta de Andalucía (BIO-302) to E.F.J., Peer reviewed